ATG5 and neoplasm: As shown in Fig 3b, tumor incidence 4 weeks after injection was significantly (p < 0.05) higher in control diet-fed mice with Atg5+/+ tumors (12/14, 86 %) than Atg5−/− tumors (5/14; 36 %).